Mark C. Schneyer, EVP, Chief Financial Officer at ACADIA PHARMACEUTICALS INC (ACAD), sold 974 shares at $25.02 ($24K) on 2023-06-08, disclosed to the SEC on 2023-06-12.
Open-market sale of $24k ACAD by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ACAD | SELL | 2026-04-07 | $60K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $160K | — | Filing → |
| ACAD | SELL | 2025-11-19 | $486K | — | Filing → |